$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2015 Q2 Form 10-Q Financial Statement

#000114420415032615 Filed on May 20, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $0.00 $113.00 $165.00
YoY Change -100.0% -31.52% -59.36%
Cost Of Revenue
YoY Change
Gross Profit $165.00
YoY Change -59.36%
Gross Profit Margin 100.0%
Selling, General & Admin $20.00K $10.00K $0.00
YoY Change 0.0%
% of Gross Profit 0.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $18.67K $9.754K $4.063K
YoY Change 14.37% 140.07% 19.82%
Operating Profit -$18.67K -$1.829K -$3.898K
YoY Change 16.53% -53.08% 30.59%
Interest Expense $3.655K $11.58K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$3.655K $0.00 -$330.00
YoY Change -100.0% 2.17%
Pretax Income -$18.63K -$11.58K -$4.228K
YoY Change 16.27% 173.96% 27.81%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$22.15K -$11.58K -$4.228K
YoY Change 38.24% 173.96% 27.81%
Net Earnings / Revenue -10250.44% -2562.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.945K -$1.972K $0.00
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $371.00 $195.00 $500.00
YoY Change -45.44% -61.0% -95.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $371.00 $195.00 $500.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $371.00 $195.00 $500.00
YoY Change -45.44% -61.0% -95.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.753K $3.129K $0.00
YoY Change -12.47%
Accrued Expenses $3.875K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.49K $35.17K $3.875K
YoY Change 186.41% 807.54% -80.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $57.49K $35.17K $3.875K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $57.49K $35.17K $3.875K
YoY Change 186.41% 807.54% -80.63%
SHAREHOLDERS EQUITY
Retained Earnings -$150.9K
YoY Change
Common Stock $5.073K $5.073K $5.073K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$57.12K -$34.97K -$3.375K
YoY Change
Total Liabilities & Shareholders Equity $371.00 $195.00 $500.00
YoY Change -45.44% -61.0% -95.0%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$22.15K -$11.58K -$4.228K
YoY Change 38.24% 173.96% 27.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 -$20.00K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 20.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 0.000 -20.00K 0.000
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 20.00K 0.000
Net Change In Cash 0.000 0.000 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $0.00 -$20.00K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2015Q1 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2014Q4 osok Related Party Forgiveness Of Note Payable Convertible Note Payable And Accrued Interest
RelatedPartyForgivenessOfNotePayableConvertibleNotePayableAndAccruedInterest
28146 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
13500 USD
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9966 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 USD
CY2015Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
30209 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22628 USD
CY2015Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1829 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
35167 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35594 USD
CY2015Q1 us-gaap Liabilities
Liabilities
35167 USD
CY2014Q4 us-gaap Liabilities
Liabilities
35594 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q1 us-gaap Cash
Cash
195 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88723 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2015Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
128768 USD
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
117185 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
-34972 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-35389 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
195 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
205 USD
CY2015Q1 us-gaap Assets
Assets
195 USD
CY2014Q4 us-gaap Assets
Assets
205 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3129 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2014Q1 us-gaap Cash
Cash
500 USD
CY2015Q1 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
USD
CY2014Q1 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
31144 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-11583 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-4228 USD
CY2015Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
1829 USD
CY2014Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9837 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4203 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19591 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11583 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
CY2015Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7581 USD
CY2014Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2015Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
12000 USD
CY2014Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19581 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
USD
CY2015Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-10 USD
CY2014Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-25 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
113 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
165 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9867 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4063 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9754 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3898 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1829 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4228 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22628 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
22628 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Debt
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyDebt
952 USD
CY2015Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
30209 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="text-decoration: underline;">Use of Estimates</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="text-decoration: underline;">Products and services, geographic areas and major customers</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</p> </div>
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2015Q1 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q1 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD

Files In Submission

Name View Source Status
0001144204-15-032615-index-headers.html Edgar Link pending
0001144204-15-032615-index.html Edgar Link pending
0001144204-15-032615.txt Edgar Link pending
0001144204-15-032615-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
osok-20150331.xml Edgar Link completed
osok-20150331.xsd Edgar Link pending
osok-20150331_cal.xml Edgar Link unprocessable
osok-20150331_def.xml Edgar Link unprocessable
osok-20150331_lab.xml Edgar Link unprocessable
osok-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v411019_10-q.htm Edgar Link pending
v411019_ex31.htm Edgar Link pending
v411019_ex32.htm Edgar Link pending